Entrectinib in NTRK fusion-positive NSCLC: Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 Meeting Abstract


Authors: Drilon, A.; Paz-Ares, L.; Doebele, R. C.; Farago, A. F.; Liu, S. V.; Chawla, S. P.; Tosi, D.; Blakely, C. M.; Krauss, J. C.; Bazhenova, L.; John, T.; Besse, B.; Wolf, J.; Seto, T.; Cho, B. C.; Rolfo, C.; Osborne, S.; Aziez, A.; Demetri, G. D.
Abstract Title: Entrectinib in NTRK fusion-positive NSCLC: Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S474
End Page: S475
Language: English
ACCESSION: WOS:000573469100541
DOI: 10.1016/j.annonc.2020.08.657
PROVIDER: wos
Notes: Meeting Abstract: 543P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon